The June 1, 2010, review article by Sideras et al, entitled “Coprescription of Tamoxifen and Medications That Inhibit CYP2D6” (J Clin Oncol 28:2768–2776, 2010), contained an error.
In Table 3, under the column “Moderate-to-Potent Inhibitors With Clearly Demonstrated or Expected In Vivo Inhibition,” the first medication for infectious diseases was given as “Terfenadine,” whereas it should have been “Terbinafine.”
The online version has been corrected in departure from the print. The authors apologize to the readers for the mistake.